Novel Antiviral Shortens COVID Illness in Outpatients, Reduces Viral Load

(MedPage Today) -- With oral simnotrelvir/ritonavir treatment in a vaccinated population, COVID-19 symptoms went away about 1.5 days earlier and SARS-CoV-2 viral loads fell, a Chinese placebo-controlled phase II/III trial found. In patients with...

https://www.medpagetoday.com/infectiousdisease/covid19/108300

Source: MedPage Today Infectious Disease - January 17, 2024 Category: Infectious Diseases Source Type: news